Mixed Micelles Made of Poly(ethylene Glycol)-phosphatidylethanolamine Conjugate and D-alpha-tocopheryl Polyethylene Glycol 1000 Succinate As Pharmaceutical Nanocarriers for Camptothecin

Overview

Journal Int J Pharm

Specialties Chemistry
Pharmacology

Date 2005 Oct 26

PMID 16242875

Citations 31

Authors

L Mu

T A Elbayoumi

V P Torchilin

Affiliations

Soon will be listed here.

Abstract

Micelles from the mixture of poly(ethylene glycol)-phosphatidyl ethanolamine conjugate (PEG-PE) and d-alpha-tocopheryl polyetheyene glycol 1000 succinate (TPGS) were prepared loaded with the poorly soluble anticancer drug camptothecin (CPT). The solubilization of CPT by the mixed micelles was more efficient than with earlier described micelles made of PEG-PE alone. CPT-loaded mixed micelles were stable upon storage and dilution and firmly retained the incorporated drug. The cytotoxicity of the CPT-loaded mixed micelles against various cancer cells in vitro was remarkably higher than that of the free drug. PEG-PE/TPGS mixed micelles may serve as pharmaceutical nanocarriers with improved solubilization capacity for poorly soluble drugs.

Citing Articles

Cationic Vitamin E-TPGS Mixed Micelles of Berberine to Neutralize Doxorubicin-Induced Cardiotoxicity via Amelioration of Mitochondrial Dysfunction and Impeding Apoptosis.

Metwally A, Ganguly S, Biomi N, Yao M, Elbayoumi T Molecules. 2024; 29(5).

PMID: 38474668 PMC: 10935258. DOI: 10.3390/molecules29051155.

Preparation, Optimization and Characterization of Fluticasoneloaded Mixed Micelles Based on Stearic Acid-g-chitosan as a Pulmonary Delivery System.

Tasharoie S, Ostad S, Amini M, Sabourian R, Gilani K Recent Adv Drug Deliv Formul. 2024; 18(1):61-76.

PMID: 38362679 DOI: 10.2174/0126673878262764240208054140.

Enhancing Ezetimibe Anticancer Activity Through Development of Drug Nano-Micelles Formulations: A Promising Strategy Supported by Molecular Docking.

Ahmed T, Ali E, Omar A, Almehmady A, El-Say K Int J Nanomedicine. 2023; 18:6689-6703.

PMID: 38026536 PMC: 10657552. DOI: 10.2147/IJN.S438704.

TPGS Decorated Liposomes as Multifunctional Nano-Delivery Systems.

Farooq M, Trevaskis N Pharm Res. 2022; 40(1):245-263.

PMID: 36376604 PMC: 9663195. DOI: 10.1007/s11095-022-03424-6.

Design, Fabrication and Evaluation of Stabilized Polymeric mixed micelles for Effective Management in Cancer Therapy.

Sandeep Chary P, Rajana N, Devabattula G, Bhavana V, Singh H, Godugu C Pharm Res. 2022; 39(11):2761-2780.

PMID: 36171346 DOI: 10.1007/s11095-022-03395-8.

References

Neuzil J, Weber T, Schroder A, Lu M, OSTERMANN G, Gellert N . Induction of cancer cell apoptosis by alpha-tocopheryl succinate: molecular pathways and structural requirements. FASEB J. 2001; 15(2):403-15. DOI: 10.1096/fj.00-0251com. View

Opanasopit P, Yokoyama M, Watanabe M, Kawano K, Maitani Y, Okano T . Block copolymer design for camptothecin incorporation into polymeric micelles for passive tumor targeting. Pharm Res. 2004; 21(11):2001-8. DOI: 10.1023/b:pham.0000048190.53439.eb. View

Wall M, Wani M . Camptothecin and taxol: discovery to clinic--thirteenth Bruce F. Cain Memorial Award Lecture. Cancer Res. 1995; 55(4):753-60. View

Hatefi A, Amsden B . Camptothecin delivery methods. Pharm Res. 2002; 19(10):1389-99. DOI: 10.1023/a:1020427227285. View

Torchilin V . Structure and design of polymeric surfactant-based drug delivery systems. J Control Release. 2001; 73(2-3):137-72. DOI: 10.1016/s0168-3659(01)00299-1. View

Maeda H, Wu J, Sawa T, Matsumura Y, Hori K . Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release. 2000; 65(1-2):271-84. DOI: 10.1016/s0168-3659(99)00248-5. View

Krishnadas A, Rubinstein I, Onyuksel H . Sterically stabilized phospholipid mixed micelles: in vitro evaluation as a novel carrier for water-insoluble drugs. Pharm Res. 2003; 20(2):297-302. DOI: 10.1023/a:1022243709003. View

Shenderova A, Burke T, Schwendeman S . Stabilization of 10-hydroxycamptothecin in poly(lactide-co-glycolide) microsphere delivery vehicles. Pharm Res. 1997; 14(10):1406-14. DOI: 10.1023/a:1012172722246. View

Lukyanov A, Torchilin V . Micelles from lipid derivatives of water-soluble polymers as delivery systems for poorly soluble drugs. Adv Drug Deliv Rev. 2004; 56(9):1273-89. DOI: 10.1016/j.addr.2003.12.004. View

10.

Jain . Delivery of molecular and cellular medicine to solid tumors. Adv Drug Deliv Rev. 1997; 26(2-3):71-90. DOI: 10.1016/s0169-409x(97)00027-6. View

11.

Tardi P, Choice E, Masin D, Redelmeier T, Bally M, Madden T . Liposomal encapsulation of topotecan enhances anticancer efficacy in murine and human xenograft models. Cancer Res. 2000; 60(13):3389-93. View

12.

Yang S, Lu L, Cai Y, Zhu J, Liang B, Yang C . Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain. J Control Release. 1999; 59(3):299-307. DOI: 10.1016/s0168-3659(99)00007-3. View

13.

Cho Y, Lee J, Lee S, Huh K, Park K . Hydrotropic agents for study of in vitro paclitaxel release from polymeric micelles. J Control Release. 2004; 97(2):249-57. DOI: 10.1016/j.jconrel.2004.03.013. View

14.

GIOVANELLA B, Hinz H, Kozielski A, STEHLIN Jr J, Silber R, POTMESIL M . Complete growth inhibition of human cancer xenografts in nude mice by treatment with 20-(S)-camptothecin. Cancer Res. 1991; 51(11):3052-5. View

15.

La S, Okano T, Kataoka K . Preparation and characterization of the micelle-forming polymeric drug indomethacin-incorporated poly(ethylene oxide)-poly(beta-benzyl L-aspartate) block copolymer micelles. J Pharm Sci. 1996; 85(1):85-90. DOI: 10.1021/js950204r. View

16.

Fassberg J, Stella V . A kinetic and mechanistic study of the hydrolysis of camptothecin and some analogues. J Pharm Sci. 1992; 81(7):676-84. DOI: 10.1002/jps.2600810718. View

17.

Wu N, Da D, Rudoll T, Needham D, Whorton A, Dewhirst M . Increased microvascular permeability contributes to preferential accumulation of Stealth liposomes in tumor tissue. Cancer Res. 1993; 53(16):3765-70. View

18.

Garcia-Carbonero R, Supko J . Current perspectives on the clinical experience, pharmacology, and continued development of the camptothecins. Clin Cancer Res. 2002; 8(3):641-61. View

19.

Barreiro-Iglesias R, Bromberg L, Temchenko M, Hatton T, Concheiro A, Alvarez-Lorenzo C . Solubilization and stabilization of camptothecin in micellar solutions of pluronic-g-poly(acrylic acid) copolymers. J Control Release. 2004; 97(3):537-49. DOI: 10.1016/j.jconrel.2004.04.007. View

20.

Hsiang Y, Liu L . Identification of mammalian DNA topoisomerase I as an intracellular target of the anticancer drug camptothecin. Cancer Res. 1988; 48(7):1722-6. View